|
1
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Voulgari A and Pintzas A:
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms,
markers and strategies to overcome drug resistance in the clinic.
Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
|
|
3
|
Trimboli AJ, Fukino K, de Bruin A, Wei G,
Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, et al:
Direct evidence for epithelial-mesenchymal transitions in breast
cancer. Cancer Res. 68:937–945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takeichi M: Cadherin cell adhesion
receptors as a morphogenetic regulator. Science. 251:1451–1455.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barr S, Thomson S, Buck E, Russo S, Petti
F, Sujka-Kwok I, Eyzaguirre A, Rosenfeld-Franklin M, Gibson NW,
Miglarese M, et al: Bypassing cellular EGF receptor dependence
through epithelial-to-mesenchymal-like transitions. Clin Exp
Metastasis. 25:685–693. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Przybylo JA and Radisky DC: Matrix
metalloproteinase-induced epithelial-mesenchymal transition: Tumor
progression at Snail's pace. Int J Biochem Cell Biol. 39:1082–1088.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huber MA, Azoitei N, Baumann B, Grünert S,
Sommer A, Pehamberger H, Kraut N, Beug H and Wirth T: NF-kappaB is
essential for epithelial-mesenchymal transition and metastasis in a
model of breast cancer progression. J Clin Invest. 114:569–581.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fuxe J and Karlsson MC: TGF-β-induced
epithelial-mesenchymal transition: A link between cancer and
inflammation. Semin Cancer Biol. 22:455–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tabasinezhad M, Samadi N, Ghanbari P,
Mohseni M, Saei AA, Sharifi S, Saeedi N and Pourhassan A:
Sphingosin 1-phosphate contributes in tumor progression. J Cancer
Res Ther. 9:556–563. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Milara J, Navarro R, Juan G, Peiró T,
Serrano A, Ramón M, Morcillo E and Cortijo J:
Sphingosine-1-phosphate is increased in patients with idiopathic
pulmonary fibrosis and mediates epithelial to mesenchymal
transition. Thorax. 67:147–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Belting M: Glycosaminoglycans in cancer
treatment. Thromb Res. 133(Suppl 2): S95–S101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pouysségur J, Dayan F and Mazure NM:
Hypoxia signalling in cancer and approaches to enforce tumour
regression. Nature. 441:437–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qazi H, Palomino R, Shi ZD, Munn LL and
Tarbell JM: Cancer cell glycocalyx mediates mechanotransduction and
flow-regulated invasion. Integr Biol (Camb). 5:1334–1343. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tarbell JM, Simon SI and Curry FR:
Mechanosensing at the vascular interface. Annu Rev Biomed Eng.
16:505–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jackson RL, Busch SJ and Cardin AD:
Glycosaminoglycans: Molecular properties, protein interactions, and
role in physiological processes. Physiol Rev. 71:481–539.
1991.PubMed/NCBI
|
|
19
|
Henry CB and Duling BR: Permeation of the
luminal capillary glycocalyx is determined by hyaluronan. Am J
Physiol. 277:H508–H514. 1999.PubMed/NCBI
|
|
20
|
Choi S, Lee H, Choi JR and Oh ES:
Shedding; towards a new paradigm of syndecan function in cancer.
BMB Rep. 43:305–310. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Couchman JR: Syndecans: Proteoglycan
regulators of cell-surface microdomains? Nat Rev Mol Cell Biol.
4:926–937. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leivonen M, Lundin J, Nordling S, von
Boguslawski K and Haglund C: Prognostic value of syndecan-1
expression in breast cancer. Oncology. 67:11–18. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barbareschi M, Maisonneuve P, Aldovini D,
Cangi MG, Pecciarini L, Mauri Angelo F, Veronese S, Caffo O,
Lucenti A, Palma PD, et al: High syndecan-1 expression in breast
carcinoma is related to an aggressive phenotype and to poorer
prognosis. Cancer. 98:474–483. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lendorf ME, Manon-Jensen T, Kronqvist P,
Multhaupt HA and Couchman JR: Syndecan-1 and syndecan-4 are
independent indicators in breast carcinoma. J Histochem Cytochem.
59:615–629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maeda T, Desouky J and Friedl A:
Syndecan-1 expression by stromal fibroblasts promotes breast
carcinoma growth in vivo and stimulates tumor angiogenesis.
Oncogene. 25:1408–1412. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Beauvais DM and Rapraeger AC: Syndecans in
tumor cell adhesion and signaling. Reprod Biol Endocrinol. 2:32004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baba F, Swartz K, van Buren R, Eickhoff J,
Zhang Y, Wolberg W and Friedl A: Syndecan-1 and syndecan-4 are
overexpressed in an estrogen receptor-negative, highly
proliferative breast carcinoma subtype. Breast Cancer Res Treat.
98:91–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Longley RL, Woods A, Fleetwood A, Cowling
GJ, Gallagher JT and Couchman JR: Control of morphology,
cytoskeleton and migration by syndecan-4. J Cell Sci.
112:3421–3431. 1999.PubMed/NCBI
|
|
29
|
Echtermeyer F, Streit M, Wilcox-Adelman S,
Saoncella S, Denhez F, Detmar M and Goetinck P: Delayed wound
repair and impaired angiogenesis in mice lacking syndecan-4. J Clin
Invest. 107:R9–R14. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Midwood KS, Valenick LV, Hsia HC and
Schwarzbauer JE: Coregulation of fibronectin signaling and matrix
contraction by tenascin-C and syndecan-4. Mol Biol Cell.
15:5670–5677. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kleeff J, Ishiwata T, Kumbasar A, Friess
H, Büchler MW, Lander AD and Korc M: The cell-surface heparan
sulfate proteoglycan glypican-1 regulates growth factor action in
pancreatic carcinoma cells and is overexpressed in human pancreatic
cancer. J Clin Invest. 102:1662–1673. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Matsuda K, Maruyama H, Guo F, Kleeff J,
Itakura J, Matsumoto Y, Lander AD and Korc M: Glypican-1 is
overexpressed in human breast cancer and modulates the mitogenic
effects of multiple heparin-binding growth factors in breast cancer
cells. Cancer Res. 61:5562–5569. 2001.PubMed/NCBI
|
|
33
|
Li J, Kleeff J, Kayed H, Felix K, Penzel
R, Büchler MW, Korc M and Friess H: Glypican-1 antisense
transfection modulates TGF-beta-dependent signaling in Colo-357
pancreatic cancer cells. Biochem Biophys Res Commun. 320:1148–1155.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yahya RS, El-Bindary AA, El-Mezayen HA,
Abdelmasseh HM and Eissa MA: Biochemical evaluation of hyaluronic
acid in breast cancer. Clin Lab. 60:1115–1121. 2014.PubMed/NCBI
|
|
35
|
Zeng Y, Adamson RH, Curry FR and Tarbell
JM: Sphingosine-1-phosphate protects endothelial glycocalyx by
inhibiting syndecan-1 shedding. Am J Physiol Heart Circ Physiol.
306:H363–H372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeng Y, Liu XH, Tarbell J and Fu BM:
Sphingosine 1-phosphate induced synthesis of glycocalyx on
endothelial cells. Exp Cell Res. 339:90–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fang XJ, Jiang H, Zhu YQ, Zhang LY, Fan QH
and Tian Y: Doxorubicin induces drug resistance and expression of
the novel CD44st via NF-kB in human breast cancer MCF-7 cells.
Oncol Rep. 31:2735–2742. 2014.PubMed/NCBI
|
|
38
|
Zhang Y, Thant AA, Hiraiwa Y, Naito Y,
Sein TT, Sohara Y, Matsuda S and Hamaguchi M: A role for focal
adhesion kinase in hyluronan-dependent MMP-2 secretion in a human
small-cell lung carcinoma cell line, QG90. Biochem Biophys Res
Commun. 290:1123–1127. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pyne NJ and Pyne S: Sphingosine
1-phosphate and cancer. Nat Rev Cancer. 10:489–503. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Payne SG, Milstien S and Spiegel S:
Sphingosine-1-phosphate: Dual messenger functions. FEBS Lett.
531:54–57. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang YL, Huang WP and Lee H: Roles of
sphingosine 1-phosphate on tumorigenesis. World J Biol Chem.
2:25–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Takabe K, Paugh SW, Milstien S and Spiegel
S: ‘Inside-out’ signaling of sphingosine-1-phosphate: Therapeutic
targets. Pharmacol Rev. 60:181–195. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rosen H, Gonzalez-Cabrera PJ, Sanna MG and
Brown S: Sphingosine 1-phosphate receptor signaling. Annu Rev
Biochem. 78:743–768. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pchejetski D, Böhler T, Stebbing J and
Waxman J: Therapeutic potential of targeting sphingosine kinase 1
in prostate cancer. Nat Rev Urol. 8:569–678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lepley D, Paik JH, Hla T and Ferrer F: The
G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to
inhibit tumor cell migration. Cancer Res. 65:3788–3795. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim ES, Kim JS, Kim SG, Hwang S, Lee CH
and Moon A: Sphingosine 1-phosphate regulates matrix
metalloproteinase-9 expression and breast cell invasion through
S1P3-Gαq coupling. J Cell Sci. 124:2220–2230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Moon A, Kim MS, Kim TG, Kim SH, Kim HE,
Chen YQ and Kim HR: H-ras, but not N-ras, induces an invasive
phenotype in human breast epithelial cells: A role for MMP-2 in the
H-ras-induced invasive phenotype. Int J Cancer. 85:176–181. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xin C, Ren S, Kleuser B, Shabahang S,
Eberhardt W, Radeke H, Schäfer-Korting M, Pfeilschifter J and
Huwiler A: Sphingosine 1-phosphate cross-activates the Smad
signaling cascade and mimics transforming growth
factor-beta-induced cell responses. J Biol Chem. 279:35255–35262.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Radisky ES and Radisky DC: Matrix
metalloproteinase-induced epithelial-mesenchymal transition in
breast cancer. J Mammary Gland Biol Neoplasia. 15:201–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Janda E, Lehmann K, Killisch I, Jechlinger
M, Herzig M, Downward J, Beug H and Grünert S: Ras and TGF [beta]
cooperatively regulate epithelial cell plasticity and metastasis:
Dissection of Ras signaling pathways. J Cell Biol. 156:299–313.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jechlinger M, Grunert S, Tamir IH, Janda
E, Lüdemann S, Waerner T, Seither P, Weith A, Beug H and Kraut N:
Expression profiling of epithelial plasticity in tumor progression.
Oncogene. 22:7155–7169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kim ES, Sohn YW and Moon A:
TGF-beta-induced transcriptional activation of MMP-2 is mediated by
activating transcription factor (ATF) 2 in human breast epithelial
cells. Cancer Lett. 252:147–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ota I, Li XY, Hu Y and Weiss SJ: Induction
of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration
program in cancer cells by Snail1. Proc Natl Acad Sci USA.
106:20318–20323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Radisky DC, Levy DD, Littlepage LE, Liu H,
Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, et
al: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and
genomic instability. Nature. 436:123–127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Moustakas A and Heldin P: TGFβ and
matrix-regulated epithelial to mesenchymal transition. Biochim
Biophys Acta. 1840:2621–2634. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
